Eye-Catching Stocks: Trimble Inc (NASDAQ:TRMB), Amarin Corporation plc (ADR) (NASDAQ:AMRN)

On Tuesday,Shares of Trimble Inc (NASDAQ:TRMB), added 0.63% and closed at $28.66 in the last trading session. The last trading range of the stock ranges between $27.48 and $28.94. Trimble (TRMB) concluded its 8th International User Conference with more than 4,400 registered attendees representing over 80 countries. Dimensions 2016 offered insight into how information technology can transform the way professionals work to achieve success. The conference featured innovative solutions in Agriculture, Construction, Civil Infrastructure, Engineering, Government, Mapping, Natural Resources, Surveying, Telecommunications, Transportation & Logistics and Utilities. Trimble Dimensions was held November 7-9 at The Venetian in Las Vegas.

“Each year, Trimble Dimensions has set new records for attendance—and this year we have done it again,” said Bryn Fosburgh, Trimble vice president. “Dimensions is truly a celebration of technology—an exclusive conference focused on how advanced solutions are transforming the way the world works. With its well-deserved reputation as one of the industry’s most comprehensive educational events, Dimensions provides a stimulating and informative experience for industry professionals.”

Amarin Corporation plc (ADR) (NASDAQ:AMRN), jumped 3.66% and closed at $3.40 in the last trading session. The last trading range of the stock ranges between $3.14 and $3.45. The company’s Market capitalization is $9852.69 Million with the total Outstanding Shares of 269.95 Million. Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. The company’s lead product includes Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999.

Leave a Reply

Your email address will not be published. Required fields are marked *